Smell Outcome and Seropositivity Titre in Post-COVID-19 Patients
Open Access
- 20 July 2023
- journal article
- research article
- Published by S. Karger AG in ORL
- Vol. 85 (6) , 305-311
Abstract
Introduction: The aims of the study were to perform an olfactory assessment on patients active and post-COVID-19 using the culturally adapted Malaysian version Sniffin’ Sticks identification smell test (mSS-SIT), to evaluate the patient olfactory outcome using a Malay short version of the Questionnaire of Olfactory Disorders-Negative Statements (msQOD-NS), as well as to evaluate seropositive titre (IgG) response using automated serology method. Methods: Score for mSS-SIT was performed during the hospitalization, when patients had tested positive for SARS-CoV-2 (during COVID-19), and repeated after they had tested negative (after COVID-19). Also, each patient completed msQOD-NS and serology SARS-CoV-2 antibodies blood test was evaluated. Results: During COVID-19, 2 of our patients were anosmia (6.5%), 22 (70.9%) were hyposmia, and 7 (22.6%) were normosmia. We repeated mSS-SIT on these same patients after COVID-19, and none of these subjects were hyposmia or anosmia, as they achieved a score >12. All our patients had scored 21 using msQOD-NS, meaning no impact on quality of life as they had regained their normal olfactory function. In this study also, we obtained no correlation between smell test and seropositivity titre COVID-19, and antibody levels gradually decreased over time till 6 months and remained stable up to 12 months. Conclusion: From this study, we know full recovery of the sense of smell can be expected post-COVID-19 infection and COVID-19 antibody persists in the body up to 12 months of infection.Keywords
This publication has 33 references indexed in Scilit:
- Projecting the transmission dynamics of SARS-CoV-2 through the postpandemic periodScience, 2020
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort studyThe Lancet Infectious Diseases, 2020
- Olfactory and gustatory dysfunctions as a clinical presentation of mild-to-moderate forms of the coronavirus disease (COVID-19): a multicenter European studyEuropean Archives of Oto-Rhino-Laryngology, 2020
- Covid-19: four fifths of cases are asymptomatic, China figures indicateBMJ, 2020
- Molecular immune pathogenesis and diagnosis of COVID-19Journal of Pharmaceutical Analysis, 2020
- Antibody Responses to SARS-CoV-2 in Patients With Novel Coronavirus Disease 2019Clinical Infectious Diseases, 2020
- Machine-learned analysis of side-differences in odor identification performanceNeuroscience, 2019
- A brief version of the questionnaire of olfactory disorders in patients with chronic rhinosinusitisInternational Forum of Allergy & Rhinology, 2019
- New chemosensory component in the U.S. National Health and Nutrition Examination Survey (NHANES): first-year results for measured olfactory dysfunctionReviews in Endocrine and Metabolic Disorders, 2016
- Gestörte Riech- und SchmeckfunktionTherapieoptionen bei Riech- und SchmeckstörungenLaryngo-Rhino-Otologie, 2005